Al-Shareef, E.; Khan, L.M.; Alsieni, M.; Karim, S.; Kamel, F.O.; Alkreathy, H.M.; Bafail, D.A.; Ibrahim, I.M.; Burzangi, A.S.; Bazuhair, M.A.
Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators. Healthcare 2023, 11, 660.
https://doi.org/10.3390/healthcare11050660
AMA Style
Al-Shareef E, Khan LM, Alsieni M, Karim S, Kamel FO, Alkreathy HM, Bafail DA, Ibrahim IM, Burzangi AS, Bazuhair MA.
Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators. Healthcare. 2023; 11(5):660.
https://doi.org/10.3390/healthcare11050660
Chicago/Turabian Style
Al-Shareef, Ebtihal, Lateef M. Khan, Mohammed Alsieni, Shahid Karim, Fatemah O. Kamel, Huda M. Alkreathy, Duaa A. Bafail, Ibrahim M. Ibrahim, Abdulhadi S. Burzangi, and Mohammed A. Bazuhair.
2023. "Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators" Healthcare 11, no. 5: 660.
https://doi.org/10.3390/healthcare11050660
APA Style
Al-Shareef, E., Khan, L. M., Alsieni, M., Karim, S., Kamel, F. O., Alkreathy, H. M., Bafail, D. A., Ibrahim, I. M., Burzangi, A. S., & Bazuhair, M. A.
(2023). Detection of Adverse Drug Reactions in COVID-19 Hospitalized Patients in Saudi Arabia: A Retrospective Study by ADR Prompt Indicators. Healthcare, 11(5), 660.
https://doi.org/10.3390/healthcare11050660